P494 Early invasive strategy for acute coronary syndromes without persistent ST-segment-elevation ? 6-month outcome of 401 consecutive high-risk patients from Zabrze registry

Invasive Strategy ◽

St Segment Elevation ◽

High Risk Patients ◽

St Segment ◽

Risk Patients ◽

Coronary Syndromes ◽

Early Invasive Strategy

Enoxaparin vs Unfractionated Heparin in High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes Managed With an Intended Early Invasive Strategy

JAMA ◽

10.1001/jama.292.1.45 ◽

2004 ◽

Vol 292 (1) ◽

Cited By ~ 223

Keyword(s):

High Risk ◽

Unfractionated Heparin ◽

Invasive Strategy ◽

St Segment Elevation ◽

High Risk Patients ◽

St Segment ◽

Risk Patients ◽

Coronary Syndromes ◽

Early Invasive Strategy

Enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-Segment elevation acute coronary syndromes managed with an intended early invasive strategy—primary results of the SYNERGY randomized trial

ACC Current Journal Review ◽

10.1016/j.accreview.2004.08.036 ◽

2004 ◽

Vol 13 (9) ◽

pp. 28

Keyword(s):

High Risk ◽

Unfractionated Heparin ◽

Randomized Trial ◽

Invasive Strategy ◽

St Segment Elevation ◽

St Segment ◽

Risk Patients ◽

Coronary Syndromes ◽

Early Invasive Strategy

Relationship between renal function and outcomes in high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from SYNERGY

International Journal of Cardiology ◽

10.1016/j.ijcard.2009.03.119 ◽

2010 ◽

Vol 144 (1) ◽

pp. 36-41 ◽

Cited By ~ 14

Author(s):

Sarah A. Spinler ◽

Kenneth W. Mahaffey ◽

Dianne Gallup ◽

Glenn N. Levine ◽

James J. Ferguson ◽

...

Keyword(s):

Renal Function ◽

High Risk ◽

St Segment Elevation ◽

High Risk Patients ◽

St Segment ◽

Risk Patients ◽

"One-Time" versus Staged Multivessel Intervention in Intermediate to Very High-Risk Patients with Non-ST-Segment Elevation Acute Coronary Syndromes

Korean Circulation Journal ◽

10.4070/kcj.2016.46.6.774 ◽

2016 ◽

Vol 46 (6) ◽

pp. 774 ◽

Cited By ~ 3

Author(s):

Xiaofan Yu ◽

Yi Li ◽

Qiancheng Wang ◽

Ming Liang ◽

Kai Xu ◽

...

Keyword(s):

High Risk ◽

St Segment Elevation ◽

High Risk Patients ◽

St Segment ◽

Risk Patients ◽

Coronary Syndromes ◽

Very High

Efficacy and Safety of Tirofiban in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes

Clinical Cardiology ◽

10.1002/clc.20475 ◽

2009 ◽

Vol 32 (9) ◽

pp. E40-E44 ◽

Cited By ~ 3

Author(s):

Zhenxian Yan ◽

YuJie Zhou ◽

Yingxin Zhao ◽

Yueping Li ◽

Xiaomin Nie ◽

...

Keyword(s):

High Risk ◽

Efficacy And Safety ◽

St Segment Elevation ◽

High Risk Patients ◽

St Segment ◽

Risk Patients ◽

Randomized Evaluation of the Safety and Efficacy of Enoxaparin Versus Unfractionated Heparin in High-Risk Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Receiving the Glycoprotein IIb/IIIa Inhibitor Eptifibatide

Circulation ◽

10.1161/01.cir.0000050144.67910.13 ◽

2003 ◽

Vol 107 (2) ◽

pp. 238-244 ◽

Cited By ~ 144

Author(s):

Shaun G. Goodman ◽

David Fitchett ◽

Paul W. Armstrong ◽

Mary Tan ◽

Anatoly Langer

Keyword(s):

High Risk ◽

Unfractionated Heparin ◽

Safety And Efficacy ◽

St Segment Elevation ◽

High Risk Patients ◽

Randomized Evaluation ◽

St Segment ◽

Risk Patients ◽

Magnitude and consequences of undertreatment of high-risk patients with non-ST segment elevation acute coronary syndromes: insights from the DESCARTES Registry

Heart ◽

10.1136/hrt.2005.079673 ◽

2006 ◽

Vol 92 (11) ◽

pp. 1571-1576 ◽

Cited By ~ 32

Author(s):

M Heras ◽

H Bueno ◽

A Bardaji ◽

A Fernandez-Ortiz ◽

H Marti ◽

...

Keyword(s):

High Risk ◽

St Segment Elevation ◽

High Risk Patients ◽

St Segment ◽

Risk Patients ◽

Racial Differences Among High-Risk Patients Presenting With Non–ST-Segment Elevation Acute Coronary Syndromes (Results from the SYNERGY Trial)††Disclosure: Drs. Mahaffey, Cohen, Newby, Ferguson, and Califf have received honoria for speaking from sanofi-aventis. Drs. Mahaffey, Ferguson, and Califf have acted as consultants for sanofi-aventis. Drs. Echols, Velazquez, Santos, and Gurfinkel have no financial relationships to disclose.

The American Journal of Cardiology ◽

10.1016/j.amjcard.2006.08.031 ◽

2007 ◽

Vol 99 (3) ◽

pp. 315-321 ◽

Cited By ~ 12

Author(s):

Melvin R. Echols ◽

Kenneth W. Mahaffey ◽

Anindita Banerjee ◽

Karen S. Pieper ◽

Amanda Stebbins ◽

...

Keyword(s):

High Risk ◽

Racial Differences ◽

St Segment Elevation ◽

High Risk Patients ◽

St Segment ◽

Risk Patients ◽

Coronary Syndromes ◽

Financial Relationships

Randomized evaluation of the safety and efficacy of enoxaparin vs. unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

ACC Current Journal Review ◽

10.1016/s1062-1458(03)00186-7 ◽

2003 ◽

Vol 12 (3) ◽

pp. 65

Author(s):

S.G. Goodman ◽

D. Fitchett ◽

P.W. Armstrong ◽

M. Tan ◽

A. Langer

Keyword(s):

High Risk ◽

Unfractionated Heparin ◽

Safety And Efficacy ◽

St Segment Elevation ◽

High Risk Patients ◽

Randomized Evaluation ◽

St Segment ◽

Risk Patients ◽

Acute rise in troponin I following percutaneous intervention is a risk factor for mortality among high-risk patients with non-ST segment elevation acute coronary syndromes

Evidence-based Cardiovascular Medicine ◽

10.1054/ebcm.2001.0439 ◽

2002 ◽

Vol 6 (1) ◽

pp. 21-22

Author(s):

Robbert J. de Winter

Keyword(s):

Risk Factor ◽

High Risk ◽

Troponin I ◽

Percutaneous Intervention ◽

St Segment Elevation ◽

High Risk Patients ◽

St Segment ◽

Risk Patients ◽